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Multiple sclerosis is a chronic inflammatory neurological condition characterized by focal and diffuse neurodegeneration and
demyelination throughout the central nervous system. Factors influencing the progression of pathology are poorly understood.
One hypothesis is that anatomical connectivity influences the spread of neurodegeneration. This predicts that measures of
neurodegeneration will correlate most strongly between interconnected structures. However, such patterns have been difficult to
quantify through post-mortem neuropathology or in vivo scanning alone. In this study, we used the complementary approaches
of whole brain post-mortem magnetic resonance imaging and quantitative histology to assess patterns of multiple sclerosis
pathology. Two thalamo-cortical projection systems were considered based on their distinct neuroanatomy and their docu-
mented involvement in multiple sclerosis: lateral geniculate nucleus to primary visual cortex and mediodorsal nucleus of the
thalamus to prefrontal cortex. Within the anatomically distinct thalamo-cortical projection systems, magnetic resonance imaging
derived cortical thickness was correlated significantly with both a measure of myelination in the connected tract and a measure
of connected thalamic nucleus cell density. Such correlations did not exist between these markers of neurodegeneration across
different thalamo-cortical systems. Magnetic resonance imaging lesion analysis depicted clearly demarcated subcortical lesions
impinging on the white matter tracts of interest; however, quantitation of the extent of lesion-tract overlap failed to demonstrate
any appreciable association with the severity of markers of diffuse pathology within each thalamo-cortical projection system.
Diffusion-weighted magnetic resonance imaging metrics in both white matter tracts were correlated significantly with a histo-
logically derived measure of tract myelination. These data demonstrate for the first time the relevance of functional anatomical
connectivity to the spread of multiple sclerosis pathology in a ‘tract-specific’ pattern. Furthermore, the persisting relationship
between metrics from post-mortem diffusion-weighted magnetic resonance imaging and histological measures from fixed tissue
further validates the potential of imaging for future neuropathological studies.
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Abbreviations: LGN-V1 = the thalamo-cortical projection system between the lateral geniculate nucleus and primary visual cortex
(optic radiations); MDT-PFC = the thalamo-cortical projection system between the mediodorsal nucleus of the thalamus and
prefrontal cortex (component of the anterior thalamic radiations)
Introduction
Multiple sclerosis is a chronic inflammatory demyelinating condi-
tion affecting the brain and spinal cord (Compston and Coles,
2008). Despite being the most prevalent disabling adult neuro-
logical diagnosis in Europe and North America (Dua et al.,
2008), our understanding of the cause, pathogenesis and patho-
physiology of the condition is incomplete (Stadelmann, 2011), and
no treatments are currently available that arrest disease progres-
sion (Lopez-Diego and Weiner, 2008). A greater understanding of
multiple sclerosis pathology is necessary to allow more effective
disease management and therapeutic intervention, yielding
improved patient outcomes.
Most early studies into multiple sclerosis focused on the most
striking feature of the disease, that of focal white matter demye-
lination; typically associating disease severity with the spatio-
temporal dissemination of sclerotic CNS lesions (Carswell, 1838;
Charcot, 1868; McDonald et al., 2001; Polman et al., 2005).
Although such focal demyelination is a well-established feature
in multiple sclerosis (Fog, 1950; Brownell and Hughes, 1962),
recent studies have strongly implicated a more global underlying
inflammatory neurodegeneration (Chard and Miller, 2009) and
highlighted the presence of more subtle pathological processes
in multiple sclerosis beyond focal plaque formation.
A number of studies have recognized more subtle grey matter
and white matter changes in addition to the white matter lesions
visible upon gross analysis (Evangelou et al., 2000b; Geurts and
Barkhof, 2008). Cortical atrophy is evident from an early stage,
presenting in patients with radiologically isolated syndrome
(Amato et al., 2012), clinically isolated syndrome (Dalton, 2004)
and early in relapsing remitting multiple sclerosis (Chard et al.,
2002). Post-mortem studies have also revealed diffuse changes
in myelination occurring in non-lesional, apparently normal-
appearing white matter (Barbosa et al., 1994; Kutzelnigg et al.,
2005; Mistry et al., 2011) and grey matter (Bø et al., 2003;
Gilmore et al., 2009), as well as evidence for suboptimal remye-
lination in the majority of chronic white matter lesions (Albert
et al., 2007). Extensive axonal damage has been demonstrated
in acute white matter lesions and normal-appearing white matter
in the progressive stage of the disease, with anatomically asso-
ciated grey matter demyelination and neuroapoptosis (Ferguson
et al., 1997; Evangelou et al., 2000b; Peterson et al., 2001).
Neuronal loss in cortical and thalamic structures has also been
reported in both relapsing remitting multiple sclerosis and progres-
sive multiple sclerosis (Cifelli et al., 2002; Wylezinska et al., 2003;
Wegner, 2006).
These observations suggest an interplay between inflammatory
demyelination and remyelination, ongoing axonal damage and
neurodegeneration (Evangelou et al., 2000b; Albert et al., 2007;
Frischer et al., 2009). Such findings have prompted a reappraisal
of the spread of multiple sclerosis pathology, the contribution of
lesions and the tissues impacted therein. However, currently too
little is known regarding the patterns in these varying pathological
processes, understanding of which could potentially explain the
heterogeneous clinical profile of the disease (Lassmann et al.,
2001; Weiner, 2009).
Investigating the association between the varying forms of
neuropathology in multiple sclerosis has proved difficult. Studies
of either neurohistology or MRI-derived data in individual white
matter pathways have suggested that neuronal loss in multiple
sclerosis can occur by Wallerian or trans-synaptic degeneration
of axons damaged by acute white matter lesions (Evangelou
et al., 2000a; Simon et al., 2000). Observations of early atrophy
in regions of extensive connectivity such as the thalamus and
other deep grey matter structures also support a mechanism by
which pathology might propagate through connected structures
(Henry et al., 2008). Whilst previous diffusion-weighted MRI
studies have observed apparent structural damage in non-lesional
white matter adjacent to multiple sclerosis lesions (Werring et al.,
2000), assessment of similar connectivity-driven effects in tract
systems with more distant associated white matter and grey
matter structures has been challenging.
Diffusion-weighted MRI offers sensitive measures of white
matter tract integrity and connectivity. This method measures
the average distance water molecules displace during a period of
time, and the signal thus reflects the constraints and directionality
imposed on water movement by the orientation of white matter
fibre bundles, their myelin and axonal structures (Beaulieu, 2002).
By measuring this diffusive motion along multiple directions, it is
possible to calculate metrics such as mean diffusivity and fractional
anisotropy. Mean diffusivity quantifies the mean apparent diffu-
sion independent of direction, while fractional anisotropy indicates
the degree of diffusion directionality and varies from zero (equal in
all directions) to one (movement completely restricted except
along one direction). Anisotropic diffusion in white matter has
been shown to primarily reflect ‘the dense packing of axons and
their inherent axonal membrane’ (Beaulieu, 2002), and a decrease
in fractional anisotropy is therefore commonly held to reflect a
reduction in white matter tract integrity. In the study of multiple
sclerosis, white matter diffusion-weighted MRI metrics have been
shown to correlate strongly with clinical features such as cognitive
and visual impairment (Ciccarelli et al., 2005; Rocca et al., 2007;
Dineen et al., 2009). A recent assessment of the corticospinal tract
and motor cortex in multiple sclerosis using diffusion-weighted
MRI has demonstrated an inverse relationship between tract in-
tegrity and cortical volume (Gorgoraptis et al., 2010). However,
in vivo studies are limited by the lack of histological correlates for
the diffusion-weighted MRI metrics and the assumption that rela-
tionships between tissue microstructure and diffusion-weighted
MRI metrics persist in complex neuropathology.
In order to assess patterns of diffuse neurodegeneration in
multiple sclerosis, we used novel post-mortem whole brain
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diffusion-weighted and structural MRI in combination with quan-
titative histology. We considered two white matter tracts and their
associated cortical and thalamic structures based on their distinct
neuroanatomy and on their documented involvement in multiple
sclerosis: the optic radiations between the lateral geniculate
nucleus and primary visual cortex (hereafter LGN-V1) and the
component of the anterior thalamic radiations between the med-
iodorsal nucleus of the thalamus and prefrontal cortex, hereafter
MDT-PFC (Ciccarelli et al., 2005; Rocca et al., 2007; Dineen
et al., 2009). Our primary aim was to test for associations be-
tween markers of diffuse neurodegeneration in the tracts and their
associated grey matter structures. Specifically, we hypothesized
that measures of diffuse neurodegeneration are more strongly
correlated in interconnected grey matter structures and their
white matter pathways, than in unconnected structures. In add-
ition, we sought to assess the potential association between sub-
cortical white matter lesion load and patterns of diffuse
degeneration in the specific tract systems under study. Our sec-
ondary aim was to investigate correlations in post-mortem
diffusion-weighted MRI metrics and quantitative histology. We
predicted that associations between fractional anisotropy, mean
diffusivity and quantitative histological metrics of white matter
integrity would persist ex vivo in the presence of neuropathology
as they do in vivo in healthy tissue (Beaulieu, 2002).
Materials and methods
Patients and samples
This study was performed using nine fixed whole brains from patients
with a diagnosis of multiple sclerosis, obtained from the UK MS Tissue
Bank (Imperial College, Hammersmith Hospital Campus, London)
(Table 1). Samples were immersion fixed and stored in 10% neutral
buffered formalin. During MRI, brains were placed in perfluoropo-
lyether (PFPE) (Fomblin LC08; Solvay Inc.). This proton-free fluid
medium produces minimal magnetic resonance signal and approxi-
mately matches the magnetic susceptibility of tissue, reducing scan
artefact, particularly at the exposed pial surface in ex cranio
post-mortem samples (Alper et al., 1980; Forster et al., 1991;
Ziegler et al., 2011). For an overview of the tissue processing and
analysis, see Fig. 1.
Magnetic resonance imaging
All scanning was undertaken on a Siemens Trio 3 T scanner in a
standard 12-channel head coil. The total experiment time for
each sample was 24 h. In each case, three averages of
diffusion-weighted data were acquired using a 3D-segmented echo
planar imaging sequence (echo time/repetition time = 122/530 ms,
bandwidth = 789 Hz/pixel, matrix size: 168  192  120, resolution
0.94  0.94  0.94 mm). Diffusion weighting was isotropically distrib-
uted along 54 directions (b = 4500 s/mm2) with six b = 0 images for a
total scan time of 6 h per average. Structural data were acquired
using a 3D balanced steady-state-free precession sequence with
radio frequency phase alternation to avoid banding artefact (echo
time/repetition time = 3.7/7.4 ms, bandwidth = 302 Hz/pixel, matrix
size: 352  330  416, resolution 0.5  0.5  0.5 mm) repeated
eight times and averaged to increase signal to noise ratio. More details
of the protocol have been published previously (Miller et al., 2011).
All magnetic resonance data were processed using components of
the FMRIB software library (FSL) (Smith et al., 2004; Woolrich et al.,
2009). Diffusion-weighted MRI data were processed using the FSL
diffusion toolbox (FDT) (Behrens et al. 2003a) with a pipeline de-
veloped in-house to compensate for gradient-induced-heating drift
and eddy-current distortions, to give maps of fractional anisotropy,
mean diffusivity and principle diffusion vectors (Miller et al., 2011).
Multi-fibre probabilistic tractography was performed (ProbtrackX,
FDT) (Behrens et al., 2007) in order to define the white matter
tracts of interest. We chose not to perform tractography in the mul-
tiple sclerosis brains as the presence of extensive pathology, along with
the low signal to noise ratio of post-mortem diffusion data, results in
highly variable tracking performance that can be challenging to inter-
pret. Tracking was therefore undertaken using in vivo data previously
acquired from nine healthy control subjects. Control diffusion-
weighted MRI data were acquired on a Siemens Sonata 1.5 T scanner
at the Oxford Centre for Magnetic Resonance, Oxford, UK, with a
maximum gradient strength of 40 mT/m. Three sets of echo-planar
images of the whole head were acquired. Diffusion weighting was
isotropically distributed along 60 directions (b = 1000 s/mm2) with
nine b = 0 images. 72  2-mm thick axial slices were acquired,
giving an isotropic resolution of 2  2  2 mm. In vivo control data
were age matched to the post-mortem multiple sclerosis cohort as far
as possible, to within a maximum of 4 years.
Tractography was undertaken using thalamic seed masks and cor-
tical way-point masks to assess the LGN-V1 and MDT-PFC tracts,
respectively. Anatomically defined thalamic and cortical masks were
manually created on a standard space template prior to registration
Table 1 Subject demographics









1 F 69 2 37 66 1198 Multiple sclerosis
2 F 74 1 33 40 929 Sepsis
3 F 78 2 45 60 435 Colonic carcinoma
4 F 79 2 55 26 1052 Pneumonia
5 M 72 2 28 59 1201 Pneumonia
6 F 50 2 22 69 1134 Breast cancer (metastasized)
7 M 66 2 15 37 1126 Prostate cancer
8 F 86 1 54 54 578 Lymphoma
9 F 60 2 11 21 539 Multiple sclerosis
1 = primary progressive; 2 = secondary progressive; F = female; M = male.
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into the respective in vivo control diffusion spaces, with reference to
the Oxford Thalamic Connectivity Atlas (Behrens et al., 2003a, b;
Johansen-Berg et al., 2005), the Harvard–Oxford Subcortical
Structural Atlas (Frazier et al., 2005) and neuroanatomical atlases
(DeArmond et al., 1989; Hirai et al., 1989). Masks representing the
prefrontal cortex and primary visual cortex were produced with specific
reference to anatomical definitions commonly accepted in previous
magnetic resonance studies (Stensaas et al., 1974; Wible et al., 1995).
During probabilistic tractography, repetitive sampling from the seed
mask region of interest computed potential streamlines through local
samples to reconstruct a tract based on voxel-wise distribution of prin-
ciple diffusion directions (5000 streamlines/seed voxel, loop check acti-
vated). Only streamlines that passed from the respective paired
thalamic region of interest mask to the ipsilateral cortical region of
interest mask were included in the output. Derived tracts were highly
comparable to atlas tracts from the John Hopkins Universtiy white-
matter tractography atlas (Hua et al., 2008) (Supplementary Fig. 1).
The derived standard space tracts were thresholded to include only
those present in at least three of nine control subjects, binarized and
transferred into both the structural and diffusion space of the individual
post-mortem brains using affine registration (FSL Linear Registration
Tool: FLIRT) (Fig. 2). Mean values of fractional anisotropy and mean
diffusivity in non-lesional tract white matter were acquired for each
tract region of interest from the corresponding region of the diffusion
space of each post-mortem multiple sclerosis brain, excluding regions
overlapping with lesion masks (Supplementary Fig. 2C and D).
Cortical regions of interest were masked on the structural
post-mortem images as regions corresponding to those sampled his-
tologically, defined using photographic images of coronal 10-mm slices
recorded before and after the region of interest tissue block was
removed. MRI cortical thickness in these regions of interest (Fig. 1D)
was subsequently determined using in-house scripts using the FSL
distancemap function (Smith et al., 2006) to compute an average
thickness value, taking as input the manual delineation of the grey
matter/white matter boundary and cortical surface. The MRI acquisi-
tion parameters required for post-mortem scanning and changes to
MRI tissue parameters with death and fixation made more automated
approaches unreliable.
Figure 1 Overview of imaging and histological analysis of non-lesional brain tissue. Brains were scanned and subsequently sampled
histologically to assess markers of neuropathology along the tract running from the mediodorsal nucleus of the thalamus to the prefrontal
cortex (A, green) and from the lateral geniculate nucleus of the thalamus to the visual cortex (not shown). MRI provided structural images
(D and I) and diffusion-weighted data yielding mean diffusivity (MD) and fractional anisotropy (FA) maps. Histological sampling of
grey matter structures [example sampled blocks from prefrontal cortex (B) and mediodorsal nucleus of the thalamus (H) shown for
illustration; V1 and lateral geniculate nucleus were also sampled] was followed by manual neuronal/glial profile counts on Luxol fast blue/
cresyl violet sections (B and H). MRI cortical thickness masking was undertaken on MRI in regions analogous to histological samples
(B and D: corresponding regions for prefrontal cortex); values were validated using histological measures (C). The grey matter structures
sampled histologically were masked in their entirety in standard structural MRI space and used as the basis for probabilistic tractography of
the tracts of interest in control in vivo brains. Paired thalamic and cortical masks were used as start points (seed masks) and end points
(target masks), respectively to yield tractography outputs (G: 3D MDT-PFC tract shown in green), which were transformed using affine
registration into the post-mortem image diffusion space. The resulting tract regions of interest (ROI) were used to derive average tract
diffusion metrics, excluding regions of lesion-tract overlap. Registered tractography outputs guided histological sampling of white matter
blocks corresponding to the tract midpoint (E). White matter sections were stained with anti-proteolipid protein stain (E: brown, myelin)
and assessed for light transmittance (T) in regions corresponding to the tract (defined in G) to quantify myelin content (1/T). Adjacent
white matter sections were stained with Palmgren silver to assess for axonal pathology in the tract using a point counting method (F). Scale
bars: B and H = 80 mm; E and F = 25 mm.
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Neurohistological sampling
All brains were sectioned coronally and examined by a clinical neuro-
pathologist to confirm a diagnosis of multiple sclerosis and to assess
for additional pathology. Blocks of 25  25  10 mm were sampled
bilaterally from the anatomically defined cortical and thalamic regions
of interest (Fig. 1B and H) documented using a C4040 digital camera
(Olympus). During the sampling of each individual brain, the corres-
ponding structural magnetic resonance images and individual tracto-
graphy results were consulted in the cutting room on a laptop
computer. In order to ensure that cortical samples were taken from
regions of the cortex subserved by the relevant white matter tract,
cortical sampling was guided by both the tractography results and
previous connectivity studies (Behrens et al., 2003b). Prefrontal
cortex blocks incorporated the middle and superior frontal gyri with
an inferior boundary medially at the paracingulate sulcus and laterally
superior to the inferior frontal sulcus, in line antero-posteriorly with the
frontal genu of the cingulate. V1 blocks were sampled at the banks of
the calcarine fissure in line antero-posteriorly with the medium trans-
verse occipital gyrus. Gross abnormalities were avoided, though in
practice this did not alter sampling of any brain under study.
Thalamo-cortical white matter was sampled consistently in a single
10 mm block at the midpoint between the thalamic and cortical
regions of interest to ensure consistent histological sampling from
each tract system (Fig. 1E and G). The decision to sample at the
tract midpoint aimed to maximize the likelihood of observing any
trans-synaptic effects propagating from either the thalamic nuclei or
the cortex. Sampling was guided by the tractography results, ensuring
blocks were consistently cut at an MRI-defined point approximately
equidistant between mediodorsal nucleus of the thalamus and pre-
frontal cortex, and lateral geniculate nucleus and V1. No sampled
block or assessed section contained lesions at a macroscopic or micro-
scopic level.
Tissue blocks were embedded in paraffin wax, sectioned at 10 mm,
and serial sections were stained with Luxol fast blue (Alfa Aesar) and
cresyl violet (ThermoFisher Scientific) for cell density analysis (Fig. 1B
and H), anti-proteolipid protein stain (AbD AbSerotec) (anti-proteolipid
protein) (Fig. 1E) for light transmittance myelin quantification and
Palmgren silver to visualize axons (Fig. 1F).
Cell density analysis
Cell profile counting was undertaken in all grey matter regions of
interest on a section selected from the middle of each block using
KS400 v.3.0 image analysis software (Carl Zeiss) on a PC receiving a
signal from a KY-F30 3CCD video camera (JVC) mounted on a BH-2
Figure 2 Results of control mediodorsal nucleus of the thalamus-prefrontal cortex tract output registration into structural space of
individual post-mortem MRI scans of multiple sclerosis brains. Structural images were obtained using a balanced steady-state-free
precession sequence. Tracts have been thresholded to display only those present in53/9 control subjects. Case numbering corresponds
to Table 1.







niversity of Adelaide, W
aite user on 21 O
ctober 2019
microscope (Olympus Optical) with a 40 objective lens. A counting
frame of 90  90 mm was superimposed over the images. The bottom
and left borders formed exclusion planes. In cortical regions of interest,
cells in layer IV were counted; both pyramidal and non-pyramidal
neurons were counted together and could be clearly distinguished
from glia on Luxol fast blue/cresyl violet sections by the presence of
Nissl substance and a visible nucleolus. Profile counting was under-
taken in 25 frames within an optically defined anatomical region of
interest using systematically random sampling in each section: the
counting frame was moved in a 2D raster pattern of defined step
lengths in the x and y directions using the vernier scale beginning at
a random position with respect to the boundaries of the region of
interest (Evangelou et al., 2001).
Histological cortical thickness analysis
In order to validate and complement MRI-derived cortical thickness
measures, histological measures of cortical thickness were taken in cor-
tical regions of interest from Luxol fast blue/cresyl violet stained sec-
tions as described previously (Pomeroy et al., 2008) (Supplementary
Fig. 3A) using ImageJ (US National Institutes of Health).
Cerebral white matter analysis
All assessment of tract white matter was undertaken using Axiovision
v4.7.2 software on a PC receiving a signal from an Axiocam MRc
(Carl-Zeiss) mounted on a BX40 microscope (Olympus. Japan) with
a 40 objective lens unless otherwise stated.
Myelin content in tract white matter samples was assessed using
light transmittance to quantify the intensity of the myelin stain in
anti-proteolipid protein-stained sections (Fig. 1E). No sampled blocks
or assessed sections contained lesions at a macroscopic or microscopic
level. The set-up was calibrated in RGB mode with fixed white balance
and incident light, using a standard slide/coverslip preparation and
light filters (6% and 25% transmittance) to calculate a linear regres-
sion (R2 = 1.00) between the camera-defined densitometric light inten-
sity and corresponding percentage maximum light transmittance (T).
Five measures of maximum light transmittance were taken in a
tractography-defined tract cross-section region of interest using a
150  150mm virtual frame on anti-proteolipid protein stained sec-
tions. The resulting values were averaged. Data are presented as 1/T
for intuitive analysis: greater light impedance suggests higher myelin
content.
Overt axonal pathology in non-lesional white matter was initially
assessed qualitatively using Palmgren silver in sections adjacent in
the tissue block to those used for myelin transmittance analysis. In
order to quantify whether more subtle axonal pathology was present
in non-lesional white matter, and its potential contribution to any
observed variation in the level of non-lesional white matter myelin-
ation, a relative measure of axonal density was derived from the
Palmgren silver-stained sections using a point sampling method. In
line with previous applications of this technique in the study of mul-
tiple sclerosis (Dziedzic et al., 2010), we assessed 10 microscopic fields
in each white matter tract region of interest with a 60 objective lens
and a digitally overlaid 25-point Chalkey array. The number of array
points crossed by one or more axons was expressed as a percentage of
the total number of array points, providing a measure of relative
axonal density (Supplementary Fig. 4). Stained axons that were clearly
continuous, in or out of the plane of view, were counted only once.
Axons passing at a tangent, but not crossing a given array point, were
not counted.
Lesion labelling and analysis
Lesion masking was undertaken on T2-weighted B0 volumes acquired
during diffusion-weighted MRI sequences. Lesions were identified as
regions of well-defined hyperintense signal, as previously described in
post-mortem multiple sclerosis tissue (De Groot et al., 2001).
Subcortical white matter lesions were manually segmented with indi-
vidual labels (Supplementary Fig. 2A and B) under the guidance of a
clinical neurologist. The resulting lesion masks were assessed in all
three orthogonal planes. Whole-brain lesion load was calculated, cor-
recting for brain volume (Supplementary Table 1). Proportional tract
lesion load was determined for each individual tract as the volume
overlap between the lesion mask in a certain individual, and the
volume of a specific tract mask for that individual, expressed as a
percentage of overall tract volume (Supplementary Fig. 2C and D).
Statistical methods
The normality of all data used in parametric correlative analysis was
confirmed using Shapiro–Wilk tests. Our primary measures were MRI-
derived cortical thickness, intensity of myelin staining in non-lesional
tract white matter, and a measure of thalamic nucleus cell density.
Pearson’s coefficient (one-tailed, P5 0.05 significant) was used in par-
tial correlations to explore intra- and inter-tract associations between
markers of diffuse neuropathology. All inter/intra-tract correlation ana-
lysis was corrected for the age of the subject at the time of death and
the post-mortem interval between death and fixation (post-mortem
interval), as these have previously been shown to have significant ef-
fects on diffusion-weighted MRI metrics (D’Arceuil and de Crespigny,
2007; Miller et al., 2011). To test the hypothesis that measures of
neurodegeneration correlate within tracts but not between tracts, we
used distinct procedures to detect any significant (unpredicted)
inter-tract associations and to ensure consistent (predicted) intra-tract
associations. Specifically, we used a conjunction test over all intra-tract
associations and an omnibus test over all inter-tract associations
(Nichols et al., 2005). The conjunction test considered the maximum
P-value across intra-tract correlations. In this stringent analysis, the
compound null hypothesis can only be disproved if all of the intra-tract
associations are significant. The omnibus test considered the minimum
P-value across all inter-tract associations. While one can never prove
the null hypothesis, this liberal test should give good power to detect
any possible inter-tract associations.
While our primary tests were performed using MRI-derived meas-
ures of cortical thickness, our preferred measure of cortical neurode-
generation, further exploratory analyses were performed to test
whether patterns of association were similar if histological measures
of cortical thickness or cortical layer IV cell counts were used to quan-
tify cortical neurodegeneration. These tests were performed using
Pearson’s coefficient (one-tailed, P5 0.05 significant) in partial correl-
ations, correcting for post-mortem interval and age.
Associations between tract lesion load and measures of diffuse neu-
rodegeneration within the thalamo-cortical projection systems were
assessed using Spearman’s rank order correlation (one-tailed,
P5 0.05 significant). The associations between cortical thickness
values derived from MRI and histological methods, and between
myelin transmittance values and relative axonal density, were assessed
using Pearson’s coefficient (one-tailed, P5 0.05 significant) in bivari-
ate correlations.
To assess the relationship between quantitative histological measures
of myelination and diffusion MRI metrics from white matter tract re-
gions, Pearson’s coefficient (one-tailed, P5 0.05 significant) was used
in partial correlations, correcting for post-mortem interval and age.







niversity of Adelaide, W
aite user on 21 O
ctober 2019
Statistical analysis was undertaken using SPSS v.19.0.1 (IBM).
Missing values were excluded pairwise. Histological and imaging
data are presented in Supplementary Table 1.
Results
Cortical thickness validation
To assess the concurrence of cortical thickness measures derived
from MRI and more traditional histological measurements, we per-
formed correlative analysis on measures derived from equivalent
cortical regions of interest from the two modalities. Overall, there
was a significant correlation between the two metrics (r = 0.621,
P4 0.001) (Supplementary Fig. 3B), which persisted in the ana-
lysis of the measures derived from individual cortical regions of
interest (Supplementary Fig. 3C and D).
Intra-tract versus inter-tract patterns
of pathology
To assess whether tract-specific patterns of pathology exist within
multiple sclerosis, we performed a correlative analysis of markers
of neurodegeneration both within and across the two distinct
thalamo-cortical projection systems, specifically investigating the
relationship between MRI cortical thickness, cell profile density in
the thalamic nucleus and the intensity of myelin staining within
the connecting tract white matter (Table 2). A conjunction test
supported the hypothesis that all intra-tract associations were sig-
nificant, such that the greater the degeneration in the cortical
region, the greater the reduction in myelination in the connected
non-lesional tract white matter and the greater the cell loss in the
associated thalamic nucleus [(minimum) r = 0.438, (maximum)
P = 0.045; Fig. 3]. By contrast, an omnibus test across all associ-
ations of measures between different thalamo-cortical projection
systems found no evidence of any significant inter-tract correl-
ations [(minimum) r = 0.318, (minimum) P = 0.115; Fig. 4].
A similar pattern was observed using histological cortical thick-
ness, once again demonstrating the contrast between positive
intra-tract correlations (Supplementary Fig. 5) and absent inter-
tract correlations (Supplementary Fig. 6) in all but a single rela-
tionship. A summary of the contrast in intra/inter-tract correlations
using both MRI and histological cortical thickness is presented in
Table 2.
Cell counts from cortical layer IV partially replicated our pattern
of positive intra-tract and absent inter-tract correlations.
For intra-tract relationships, significant positive correlations
were found between layer IV neuronal counts and the intensity
of myelin staining in non-lesional tract white matter
(LGN-V1: r = 0.471, P = 0.038; MDT-PFC: r = 0.591, P = 0.013)
(Supplementary Fig. 7A and C), but no such trend was observed
between layer IV neuronal counts and a measure of thalamic
nucleus cell density (all P4 0.055) (Supplementary Fig. 7B and
D). All inter-tract relationships were non-significant (all
P40.112) (Supplementary Fig. 8).
Axonal density
In order to assess the relationship between axonal density and
diffuse changes in myelination observed in thalamo-cortical non-
lesional white matter (Supplementary Fig. 9A and C), we used a
point sampling method to gain a quantitative measure of relative
axonal density using Palmgren silver in white matter sections ad-
jacent to those used in myelin light transmittance analysis
(Supplementary Fig. 9B and D).
Despite the substantial variation in myelin transmittance across
the tracts, there was no clear relationship between changes in
tract myelination and axonal density (Supplementary Fig. 9E and
F). Although it is possible that the detection of subtle relationships
between diffuse demyelination and changes in axonal density was
beyond the resolution of the applied point sampling method, the
current methods were sufficiently robust to detect any overt
changes in axonal density and have been applied widely in the
field of multiple sclerosis (Brück et al., 1997; Dziedzic et al., 2010).
The oblique and non-unified directionality of axonal fibres in the
subcortical white matter precluded more detailed quantitative ana-
lysis of axonal density in this region as has been previously under-
taken in specific tracts of the spinal cord (DeLuca et al., 2004;
Tallantyre et al., 2009).
Lesion analysis
Lesion masking across the nine brains under study yielded a range
of whole-brain lesion load (Supplementary Table 1), but with a
common stereotypical distribution (Supplementary Fig. 2B). There
was a predominantly periventricular pattern, ranging from large
confluences to small isolated structures, often with perpendicular
ovoid extensions from the ventricular border (McAlpine and
Compston, 2010; Reimer et al., 2010).









V1 cortical thickness (mm) MRI r = 0.438 P = 0.045 r = 0.512 P = 0.021 r = 0.088 P = 0.377 r = 0.256 P = 0.178
Histology r = 0.549 P = 0.014 r = 0.450 P = 0.040 r = 0.106 P = 0.353 r = 0.262 P = 0.173
Prefrontal cortex
cortical thickness (mm)
MRI r = 0.136 P = 0.308 r = 0.318 P = 0.115 r = 0.485 P = 0.033 r = 0.540 P = 0.019
Histology r = 0.276 P = 0.150 r = 0.325 P = 0.110 r = 0.093 P = 0.371 r = 0.640 P = 0.005
An overview of the significance of the correlations observed across the two thalamo-cortical projection systems under study using both MRI and histological cortical
thickness values. Values in bold P5 0.05; otherwise P4 0.05. T = light transmittance. LGN = lateral geniculate nucleus; MDT = mediodorsal nucleus of the thalamus;
PFC = prefrontal cortex.
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Histological assessment of these plaques demonstrated a
clear reduction in myelination (Supplementary Fig. 10A, E and I)
but considerable variability in axonal density, with some
demonstrating minimal axonal disruption and others showing
clear loss (Supplementary Fig. 10B, F and J). In order to assess
the potential contribution of tract lesion load to patterns of diffuse
degenerative processes in the connected tract structures, we
assessed the relationships between tract lesion load (percentage
of tract disrupted by lesion) (Supplementary Fig. 2C and D) and
measures of diffuse pathology throughout the grey matter and
white matter structures in the associated tract (Supplementary
Fig. 11). Despite the wide range of lesion disruption, particularly
from the LGN-PFC tract system, no significant association
was observed between increased tract lesion burden and the
expected increase in cortical atrophy, cortical layer IV cell loss,
diffuse reductions in non-lesional white matter myelination, or
cell loss in the associated thalamic nucleus in either tract
(Spearman’s rank-order coefficient, all P40.099, data not
shown).
Our measures highlight a clear tract-specific relationship be-
tween cortical neurodegeneration and diffuse changes in myelin-
ation in non-lesional tract white matter. However, a similar
relationship is not observed between tract white matter lesion




It has previously been suggested that post-mortem diffusion-
weighted MRI metrics may not reflect tissue microstructure to
the same extent as they do in vivo (Shepherd et al., 2009a, b),
which may be the source of lower fractional anisotropy and mean
diffusivity values in our data compared to that seen in vivo (Miller
et al., 2011). We assessed correlations between the intensity of
myelin staining in non-lesional tract white matter quantified
through light transmittance analysis and diffusion-weighted MRI
metrics in the tracts studied, excluding regions of tract-lesion over-
lap (Supplementary Fig. 2C and D). The intensity of myelin stain-
ing in the white matter tracts was significantly correlated with
both tract fractional anisotropy (r = 0.307, P = 0.041) and tract
mean diffusivity (r =  0.302, P = 0.044) (Fig. 5). Despite global
reductions in these parameters, greater tract myelination was asso-
ciated with higher values of fractional anisotropy and lower values
of mean diffusivity.
Discussion
The primary aim of this study was to investigate patterns of dif-
fuse neurodegeneration in multiple sclerosis. Using novel
Figure 3 Significant ‘intra-tract’ correlations between MRI cortical thickness and both (A and C) a measure of thalamic nucleus cell
density and (B and D) the intensity of staining for proteolipid protein (‘level of myelination’) in both LGN-V1 and MDT-PFC. T = light
transmittance.
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post-mortem MRI techniques combined with quantitative hist-
ology, we have demonstrated that correlations exist between mar-
kers of diffuse neurodegeneration within, but not between,
anatomically distinct tracts and grey matter structures in the mul-
tiple sclerosis brain. These data provide evidence consistent with
the hypothesis that patterns of anatomical connection influence
the spread and progression of neurodegeneration in multiple scler-
osis. Focal changes in MRI cortical thickness show a clear
intra-tract correlation with diffuse changes elsewhere in the asso-
ciated tract system—a pattern almost completely reproduced
using traditional histological metrics of cortical thickness
(Supplementary Figs. 5 and 6). The observation that neuronal
density in layer IV of the cortical regions of interest partially repli-
cated our pattern of positive intra-tract and absent inter-tract cor-
relations (Supplementary Figs. 7 and 8) was further supportive of
some trans-synaptic effect, given that layer IV is traditionally con-
sidered a major input for thalamo-cortical afferents from thalamic
relay nuclei (Jones, 1998). The patterns observed again suggest
that the reduced integrity non-lesional thalamo-cortical tract white
matter is associated with neurodegeneration in anatomically con-
nected cortical regions.
The anatomical specificity of our relationships supports the hy-
pothesis that neurodegeneration within multiple sclerosis is driven
by a tract-specific process, implying a link between diffuse
changes in the myelination of non-lesional white matter and neu-
rodegeneration in anatomically connected regions. These findings
are in line with previous studies suggestive of trans-synaptic or
Wallerian degeneration in multiple sclerosis (Evangelou et al.,
2000a; Simon et al., 2000). Axonal staining did not demonstrate
any overt pathology in the regions of subcortical non-lesional tract
white matter under study (Supplementary Fig. 9), particularly
in comparison with that seen in areas with lesions
(Supplementary Fig. 10). Measures of relative axonal density
derived from point sampling techniques applied in these white
matter tracts showed no relationship with measures of tract mye-
lination. Previous studies of multiple sclerosis have reported both
trans-synaptic axonal pathology (Dziedzic et al., 2010) and diffuse
reductions in myelination in non-lesional white matter (Leary
et al., 1999; Kutzelnigg et al., 2005). The lack of any association
between diffuse reductions in tract myelin staining and clear con-
current reductions in tract axonal density leads us to speculate that
the process observed here is the true loss of myelin, rather than a
reduction in myelin levels secondary to axonal loss. Although it is
impossible to comment on the temporal dynamics of multiple
sclerosis pathology from our data, the results suggest that the
diffuse loss of myelin may play a key role in propagating the
Figure 4 Absence of significant ‘inter-tract’ correlations between MRI cortical thickness and both (A and C) a measure of thalamic
nucleus cell density and (B and D) the intensity of staining for proteolipid protein (‘level of myelination’) in both LGN-V1 and MDT-PFC.
T = light transmittance.
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kind of tract specific patterns in neuropathological markers
observed in this study.
The observation of clearly demarcated lesions impinging to a
varying extent on the tracts under study (Supplementary Table 1
and Supplementary Fig. 2C and D) provides an opportunity to
evaluate the relationship between plaque related pathology and
the observed process of diffuse degeneration in the specific
thalamo-cortical projection systems. Quantitative analysis of pro-
portional lesion load impinging upon the individual tracts failed to
demonstrate any appreciable association between focal lesion load
and the severity of neurodegeneration observed therein
(Supplementary Fig. 11). This is perhaps unsurprising given the
complex and varying relationship between multiple sclerosis
lesion load and a range of both pathological and functional metrics
of disease severity and progression (Confavreux et al., 2003;
DeLuca et al., 2006; Kremenchutzky et al., 2006; Scalfari et al.,
2010). Given the patients included in this study were in the late,
progressive stage of the disease, the relationship between tract
focal lesion load and diffuse tract pathology may be blurred by
a plateau earlier in disease: a phenomenon described in a subset of
pathological and clinical studies of multiple sclerosis (Li et al.,
2006; Sormani et al., 2009; Caramanos et al., 2012). As in a
recent study of multiple sclerosis lesion load in the visual pathway
and atrophy in the lateral geniculate nucleus (Sepulcre et al.,
2009), it is possible that a clearer relationship between tract
lesion load and subtle tract pathology may be observed in a
more varied patient sample: the biases of post-mortem studies
certainly apply here. While it would be favourable to evaluate
the relationship between tract lesion load and diffuse neurodegen-
erative tract pathology across a broad range of patients with
relapsing remitting multiple sclerosis and progressive multiple scler-
osis, the restricted availability of the post-mortem tissue required
to apply the novel imaging/histological approach makes such an
investigation unfeasible at present.
Previous evidence for tract-specific associations between
changes in myelination and neurodegeneration in multiple sclerosis
have been confined mainly to the optic nerves and central visual
pathway by virtue of their involvement in optic neuritis.
Degeneration in the lateral geniculate nucleus associated with
optic nerve dysfunction has been acknowledged for some time
(Goldby, 1957), and animal models have demonstrated retrograde
degeneration in the optic pathways following tumour necrosis
factor alpha-induced optic neuropathy (Madigan, 1996). In mul-
tiple sclerosis, histological studies have correlated optic nerve
axonal loss with parvocellular atrophy in the lateral geniculate nu-
cleus in humans (Evangelou et al., 2001b). MRI studies have
associated visual disability in multiple sclerosis optic neuritis with
both tractography-defined alterations in optic radiation integrity
and structure (Ciccarelli et al., 2005) and magnetization transfer
ratio changes in the visual cortex (Audoin et al., 2006). Suggestion
of trans-synaptic effects in the mediodorsal nucleus of the
thalamus-prefrontal cortex tract has not been documented previ-
ously in multiple sclerosis, but there is evidence for correlations
between cognitive dysfunction and prefrontal cortex atrophy
(Morgen et al., 2006; Portaccio et al., 2006), as well as changes
in anterior thalamic radiation integrity on diffusion-weighted MRI
(Dineen et al., 2009). The specificity of our correlations supports
the notion that connectivity-driven degeneration exists in multiple
sclerosis above and beyond the generalized degenerative processes
previously reported in the disease (Lindberg et al., 2004).
Our findings concur with previous reports suggesting that focal
lesions fall short of explaining the apparent diffuse measures of
degeneration evaluated in this study. The driving forces behind
these diffuse pathological changes and the robust tract-specific
pattern observed are not completely understood but are likely to
reflect a complex interplay between chronic inflammation
(Kutzelnigg et al., 2005) and the effects of anatomical connectiv-
ity in the brain. Further evaluation of the relationship between
chronic inflammation and the tract-specific effects on pathology
using this novel imaging/histological strategy may provide valu-
able insight into the mechanism of tract-specific degeneration
observed in this study. A better understanding of the underlying
Figure 5 Correlations between intensity of staining for proteolipid protein in non-lesional tract white matter and tractography-derived
diffusion-weighted MRI metrics, excluding tract-lesion overlap. Correlations (Pearson’s partial correlation coefficient corrected for
post-mortem interval and age) between (A) tract fractional anisotropy and tract myelin proteolipid protein stain intensity and (B) tract
mean diffusivity and tract myelin proteolipid protein stain intensity. T = light transmittance.
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mechanisms could offer the potential for targeted early thera-
peutic intervention to arrest the cascade of molecular processes
leading to degeneration in distant but highly connected structures
following focal insults.
Beyond evidence for the mechanisms of pathogenesis in mul-
tiple sclerosis, the findings presented here have a more direct diag-
nostic potential. The observation that cortical thickness derived
from both histological and MRI data correlated significantly with
neurodegenerative processes in deeper connected regions may be
clinically useful in the diagnosis and assessment of patients with
multiple sclerosis. Cortical atrophy is well described in multiple
sclerosis, even in the early stages of the disease (Sailer et al.,
2003; Dalton, 2004; Calabrese et al., 2007; Amato et al.,
2012). Patterns of focal cortical atrophy have been reported pre-
viously in large imaging studies using standard diagnostic
T1-weighted MRI (Charil et al., 2007). Measures of cortical thick-
ness could therefore provide a welcome biomarker beyond lesion
load for the early assessment of diffuse disease activity to inform
clinical decisions in multiple sclerosis, particularly as novel disease
modifying therapeutic regimes may place an emphasis on early
intervention (Goodin et al., 2009; Gilmore et al., 2010).
In addition to disease-specific findings, the data presented here
suggest the persistence of the relationship between levels of mye-
lination and corresponding diffusion-weighted MRI-derived tract
fractional anisotropy and mean diffusivity in post-mortem fixed
tissue (Fig. 5), supporting previous findings from studies of unfixed
multiple sclerosis brain slices (Schmierer et al., 2007). This implies
that underlying tissue microstructure continues to impact diffu-
sion-weighted MRI metrics in fixed post-mortem brains, despite
a global reduction in diffusion values and is of major relevance to
future neuropathological study.
Unfixed tissue imaged rapidly after death is preferable for
post-mortem scanning studies (Schmierer et al., 2007), but fixed
samples are more readily available and convenient in terms of both
storage and the maintenance of tissue integrity over time.
However, the effect of post-mortem interval (time between
death and fixation) and scan interval (time between fixation and
scanning) on diffusion-weighted imaging and its reflection of
tissue microstructure is controversial. Many argue that brain
banks must address this issue if tissue is to be suitable for complex
neuroimaging experiments (Grinberg et al., 2008). It has been
demonstrated that post-mortem interval globally reduces
diffusion-weighted MRI metrics in controlled rodent (D’Arceuil
and de Crespigny, 2007), porcine (Widjaja et al., 2009) and
donated human tissue (Kim et al., 2009), although scan interval
does not have the same effect (Yong-Hing et al., 2005; Dyrby
et al., 2010). Post-fixation degeneration has also been observed as
extensive coarse hypointensities on MRI, but only after a period of
49 years in fixative (van Duijn et al., 2011). Further, acquisition
protocols, data processing methods and pipelines optimized for
use in vivo are unlikely to perform well post-mortem without
careful adaptation (Pfefferbaum et al., 2004; Miller et al.,
2011). These studies suggest that it is necessary to exercise cau-
tion when interpreting post-mortem data using assumptions from
experience of in vivo imaging. However, with due care and the
use of recent brain bank acquisitions, post-mortem scanning
studies can offer novel structural insight on a global scale not
seen in histological analysis alone.
Methodological limitations
The number of subjects in this study was relatively low due to the
limited availability of samples and the extensive resources required
for scanning and histological analysis. Control brains were not
included; however, the degenerative markers studied are all well
established in multiple sclerosis (Trapp and Nave, 2008), and given
the study’s aim to assess patterns of pathology across a range of
patients with multiple sclerosis, the available resources were better
directed at the study of a larger number of brains with a definitive
multiple sclerosis diagnosis. Furthermore, given our investigation
of intra-tract versus inter-tract patterns, individual subjects are
effectively self-referencing. The r-values presented in the intra-
versus inter-tract analysis were relatively low; however, the con-
trasting patterns of significance in correlations observed within and
between the thalamo-cortical systems studied were in line with
our predictions and suggest that our study was sufficiently well
powered to detect meaningful relationships between measures.
Similarly, the r-values presented in the correlations between
diffusion-weighted imaging–MRI metrics and histological myelin
quantification are reasonably low; this is expected to some extent
as diffusion-weighted imaging–MRI metrics post-mortem are likely
to be affected by factors in addition to myelination and other
anatomical structures whose contribution is well defined in vivo
(Beaulieu, 2002).
It is not possible to definitively prove the null hypothesis that
there is no relationship between measures of cortical thickness in
one tract projection system and degeneration in the white matter
tract and thalamic nucleus of another. A lack of significant results
might merely reflect the fact that our tests are insufficiently sen-
sitive to detect a relationship. However, given the positive
intra-tract relationships shown here, we believe that our tests
are sufficiently sensitive to demonstrate a relationship where one
exists and therefore are strongly indicative of an absence of
inter-tract relationships.
Conclusion
This study demonstrates the presence of tract-specific patterns of
pathology in multiple sclerosis, providing further evidence that dif-
fuse neurodegeneration and non-lesional reductions in myelination
previously associated with acute inflammation are linked in mul-
tiple sclerosis. Whilst the contribution of lesions to this pattern in
diffuse pathology remains unclear, this finding offers the potential
to guide further study of disease mechanisms for therapeutic inter-
vention and highlights the utility of cortical thickness in the diag-
nosis or assessment of patients with multiple sclerosis. The
detection of these patterns using post-mortem diffusion-weighted
MRI and histology, along with the validation of diffusion-weighted
MRI metrics in fixed brain tissue, demonstrate the relevance of this
novel approach to future study in the field of neuropathology.
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Dyrby TB, Baaré WFC, Alexander DC, Jelsing J, Garde E, Søgaard LV. An
ex vivo imaging pipeline for producing high-quality and
high-resolution diffusion-weighted imaging datasets. Hum Brain
Mapp 2010; 32: 544–63.
Dua , et al. Atlas: Multiple Sclerosis Resources in the World 2008.
Geneva: World Health Organisation; 2008.
Dziedzic T, Metz I, Dallenga T, König FB, Müller S, Stadelmann C, et al.
Wallerian degeneration: a major component of early axonal pathology
in multiple sclerosis. Brain Pathol 2010; 20: 976–85.







niversity of Adelaide, W
aite user on 21 O
ctober 2019
Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM.
Regional axonal loss in the corpus callosum correlates with cerebral
white matter lesion volume and distribution in multiple sclerosis. Brain
2000a; 123: 1845–9.
Evangelou N, Esiri M, Smith S. Quantitative pathological evidence for
axonal loss in normal appearing white matter in multiple sclerosis.
Ann Neurol 2000b; 47: 391–5.
Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM.
Size-selective neuronal changes in the anterior optic pathways suggest
a differential susceptibility to injury in multiple sclerosis. Brain 2001;
124: 1813–20.
Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute
multiple sclerosis lesions. Brain 1997; 120: 393–9.
Fog T. Topographic distribution of plaques in the spinal cord in multiple
sclerosis. Arch Neurol Psychiatry 1950; 63: 382.
Forster E, Mazzetti C, Pompili M. The effect of molecular structure on
the properties of dielectric fluids. IEEE Trans Dielectr Electr Insul 1991;
26: 749–54.
Frazier JA, Chiu S, Breeze JL, Makris N, Lange N, Kennedy DN, et al.
Structural brain magnetic resonance imaging of limbic and thalamic
volumes in pediatric bipolar disorder. Am J Psychiatry 2005; 162:
1256–65.
Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H,
Schmidbauer M, et al. The relation between inflammation and
neurodegeneration in multiple sclerosis brains. Brain 2009; 132:
1175–89.
Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis.
[Review]. Lancet Neurol 2008; 7: 841–51.
Gilmore CP, Donaldson I, Bø L, Owens T, Lowe J, Evangelou N. Regional
variations in the extent and pattern of grey matter demyelination in
multiple sclerosis: a comparison between the cerebral cortex, cerebellar
cortex, deep grey matter nuclei and the spinal cord. J Neurol
Neurosurg Psychiatry 2009; 80: 182–7.
Gilmore C, Cottrell D, Scolding N, Wingerchuk D, Weinshenker B,
Boggild M. A window of opportunity for no treatment in early multiple
sclerosis? Mult Scler 2010; 16: 756–9.
Goldby F. A note on transneuronal atrophy in the human lateral genicu-
late body. J Neurol Neurosurg Psychiatry 1957; 20: 202–7.
Goodin D, Bates D. Review: Treatment of early multiple sclerosis: the
value of treatment initiation after a first clinical episode. Mult Scler
2009; 15: 1175–82.
Gorgoraptis N, Wheeler-Kingshott CA, Jenkins TM, Altmann DR,
Miller DH, Thompson AJ. Combining tractography and cortical meas-
ures to test system-specific hypotheses in multiple sclerosis. Mult Scler
2010; 16: 555–65.
Grinberg LT, Amaro E Jr, Teipel S, Santos dos DD, Pasqualucci CA,
Leite REP, et al. Assessment of factors that confound MRI and neuro-
pathological correlation of human postmortem brain tissue. Cell Tissue
Banking 2008; 9: 195–203.
Henry RG, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML,
Pelletier D. Regional grey matter atrophy in clinically isolated syn-
dromes at presentation. J Neurol Neurosurg Psychiatry 2008; 79:
1236–44.
Hirai T, Jones EG. A new parcellation of the human thalamus on the
basis of histochemical staining. Brain Res 1989; 14: 1–34.
Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich DS, et al. Tract
probability maps in stereotaxic spaces: analyses of white matter
anatomy and tract-specific quantification. NeuroImage 2008; 39:
336–47.
Johansen-Berg H, Behrens TEJ, Sillery E, Ciccarelli O, Thompson AJ,
Smith SM, et al. Functional-anatomical validation and individual varia-
tion of diffusion tractography-based segmentation of the human tha-
lamus. Cereb Cortex 2005; 15: 31–9.
Jones EG. Viewpoint: the core and matrix of thalamic organization.
Neuroscience 1998; 85: 331–45.
Kim TH, Zollinger L, Shi XF, Rose J, Jeong EK. Diffusion tensor imaging
of ex vivo cervical spinal cord specimens: the immediate and long-term
effects of fixation on diffusivity. Anat Rec 2009; 292: 234–41.
Kremenchutzky M, Rice GPA, Baskerville J, Wingerchuk DM, Ebers GC.
The natural history of multiple sclerosis: a geographically based study
9: observations on the progressive phase of the disease. Brain 2006;
129: 584–94.
Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H,
Bergmann M, et al. Cortical demyelination and diffuse white matter
injury in multiple sclerosis. Brain 2005; 128: 2705–12.
Lassmann H, Brück W, Lucchinetti C. Heterogeneity of multiple sclerosis
pathogenesis: implications for diagnosis and therapy. Trends Mol Med
2001; 7: 115–21.
Leary SM, Davie CA, Parker GJ, Stevenson VL, Wang L, Barker GJ, et al.
1H magnetic resonance spectroscopy of normal appearing white
matter in primary progressive multiple sclerosis. J Neurol 1999; 246:
1023–6.
Li DKB, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F, et al. MRI T2
lesion burden in multiple sclerosis: a plateauing relationship with clin-
ical disability. Neurology 2006; 66: 1384–9.
Lindberg RLP, De Groot CJA, Certa U, Ravid R, Hoffmann F, Kappos L,
et al. Multiple sclerosis as a generalized CNS disease—comparative
microarray analysis of normal appearing white matter and lesions in
secondary progressive MS. J Neuroimmunol 2004; 152: 154–67.
Lopez-Diego RS, Weiner HL. Novel therapeutic strategies for multiple
sclerosis—a multifaceted adversary. Nat Rev Drug Discov 2008; 7:
909–25.
Madigan MC. Preliminary morphometric study of tumor necrosis factor-
alpha (TNF alpha)-induced rabbit optic neuropathy. Neurol Res 1996;
18: 233–6.
McAlpine D, Compston A. McAlpine’s multiple sclerosis. 4th edn.
London: Churchill Livingstone; 2005.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P,
Lublin FD, et al. Recommended diagnostic criteria for multiple scler-
osis: Guidelines from the international panel on the diagnosis of mul-
tiple sclerosis. Ann Neurol 2001; 50: 121–7.
Miller KL, Stagg CJ, Douaud G, Jbabdi S, Smith SM, Behrens TEJ, et al.
Diffusion imaging of whole, post-mortem human brains on a clinical
MRI scanner. NeuroImage 2011; 57: 167–81.
Morgen K, Sammer G, Courtney SM, Wolters T, Melchior H, Blecker CR,
et al. Evidence for a direct association between cortical atrophy and
cognitive impairment in relapsing–remitting MS. NeuroImage 2006;
30: 891–8.
Mistry N, Tallantyre EC, Dixon JE, Galazis N, Jaspan T, Morgan PS, et al.
Focal multiple sclerosis lesions abound in ‘normal appearing white
matter’. Mult Scler 2011; 17: 1313–23.
Nichols T, Brett M, Andersson J, Wager T, Poline J-B. Valid conjunc-
tion inference with the minimum statistic. NeuroImage 2005; 25:
653–60.
Peterson JW, Bø L, Mörk S, Chang A, Trapp BD. Transected neurites,
apoptotic neurons, and reduced inflammation in cortical multiple scler-
osis lesions. Ann Neurol 2001; 50: 389–400.
Pfefferbaum A, Sullivan EV, Adalsteinsson E, Garrick T, Harper C.
Postmortem MR imaging of formalin-fixed human brain.
NeuroImage 2004; 21: 1585–95.
Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L,
et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the
“McDonald Criteria”. Ann Neurol 2005; 58: 840–6.
Pomeroy IM, Jordan EK, Frank JA, Matthews PM, Esiri MM. Diffuse
cortical atrophy in a marmoset model of multiple sclerosis. Neurosci
Lett 2008; 437: 121–4.
Portaccio E, Amato MP, Bartolozzi ML, Zipoli V, Mortilla M, Guidi L,
et al. Neocortical volume decrease in relapsing–remitting multiple scler-
osis with mild cognitive impairment. J Neurol Sci 2006; 245: 195–9.
Reimer P, Parizel PM, Meaney JFM, Stichnoth FA. Clinical MR Imaging.
Berlin: Springer Verlag; 2010.
Rocca MA, Pagani E, Absinta M, Valsasina P, Falini A, Scotti G, et al.
Altered functional and structural connectivities in patients with MS: a
3-T study. Neurology 2007; 69: 2136–45.
Sailer M. Focal thinning of the cerebral cortex in multiple sclerosis. Brain
2003; 126: 1734–44.







niversity of Adelaide, W
aite user on 21 O
ctober 2019
Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M,
et al. The natural history of multiple sclerosis: a geographically
based study 10: relapses and long-term disability. Brain 2010; 133:
1914–29.
Schmierer K, Wheeler-Kingshott CAM, Boulby PA, Scaravilli F,
Altmann DR, Barker GJ, et al. Diffusion tensor imaging of post-mortem
multiple sclerosis brain. NeuroImage 2007; 35: 467–77.
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